Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Meager

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Blood|January 16, 2010
Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?Anthony Meager, Isabelle Cludts, Robin Thorpe, et al.
Cytokine|May 19, 2005
Biological activity of interleukins-28 and -29: comparison with type I interferonsAnthony Meager, Kumuthini Visvalingam, Paula Dilger, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 24, 2014
Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1)Anthony Meager, Alan Heath, Paula Dilger, et al.
Journal of Immunological Methods|January 2, 2007
Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinationsSimon Caserman, Viktor Menart, Rose Gaines Das, et al.
Journal of Immunological Methods|July 16, 2008
A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cellsMichelle McClements, Stella Williams, Christine Ball, et al.
European Journal of Immunology|May 17, 2011
Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implicationsKai Kisand, Desa Lilic, Jean-Laurent Casanova, et al.
European Cytokine Network|April 6, 2005
Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip regionIrena Fonda, Mojca Pernus, Vladka Gaberc-Porekar, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 26, 2013
Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography methodMaria El Ghazaly, Anthony Meager, Heidi Zikry, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 9, 2010
An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta productsAnthony Meager, Carl Dolman, Paula Dilger, et al.
FEBS Letters|April 13, 2023
Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1Bergithe E Oftedal, Nicolas Delaleu, David Dolan, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Blood|January 16, 2010
Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?Anthony Meager, Isabelle Cludts, Robin Thorpe, et al.
Cytokine|May 19, 2005
Biological activity of interleukins-28 and -29: comparison with type I interferonsAnthony Meager, Kumuthini Visvalingam, Paula Dilger, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 24, 2014
Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1)Anthony Meager, Alan Heath, Paula Dilger, et al.
Journal of Immunological Methods|January 2, 2007
Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinationsSimon Caserman, Viktor Menart, Rose Gaines Das, et al.
Journal of Immunological Methods|July 16, 2008
A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cellsMichelle McClements, Stella Williams, Christine Ball, et al.
European Journal of Immunology|May 17, 2011
Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implicationsKai Kisand, Desa Lilic, Jean-Laurent Casanova, et al.
European Cytokine Network|April 6, 2005
Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip regionIrena Fonda, Mojca Pernus, Vladka Gaberc-Porekar, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 26, 2013
Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography methodMaria El Ghazaly, Anthony Meager, Heidi Zikry, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 9, 2010
An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta productsAnthony Meager, Carl Dolman, Paula Dilger, et al.
FEBS Letters|April 13, 2023
Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1Bergithe E Oftedal, Nicolas Delaleu, David Dolan, et al.
Pageof 4